CERULEAN PHARMA INC.
Patent Owner
Stats
- 25 US PATENTS IN FORCE
 - 4 US APPLICATIONS PENDING
 - Apr 04, 2017 most recent publication
 
Details
- 25 Issued Patents
 - 0 Issued in last 3 years
 - 0 Published in last 3 years
 
- 1,014 Total Citation Count
 - Sep 05, 2003 Earliest Filing
 - 67 Expired/Abandoned/Withdrawn Patents
 
Patent Activity in the Last 10 Years
Technologies
						Intl Class
						Technology
						Matters
						Rank in Class
					
					Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More | 
Recent Publications
						
							Publication #
							Title
							Filing Date
							Pub Date
							Intl Class
						
					
					
						
					
					2014/0094,432 METHODS AND SYSTEMS FOR POLYMER PRECIPITATION AND GENERATION OF PARTICLESOct 01, 13Apr 03, 14[A61K]
					Recent Patents
						
							Patent #
							Title
							Filing Date
							Issue Date
							Intl Class
						
					
					
						
					
					9610360 Polymer drug conjugates with tether groups for controlled drug deliveryJun 20, 13Apr 04, 17[A61K, B82Y]
9598503 Methods and systems for polymer precipitation and generation of particlesApr 17, 13Mar 21, 17[C08B]
9550860 Cyclodextrin-based polymers for therapeutics deliveryOct 24, 13Jan 24, 17[A61K, C08G, B82Y, C08F, G06Q, C08B, G06F]
8609081 Cyclodextrin-based polymers for therapeutics deliveryJan 11, 13Dec 17, 13[A61K, C08G, C08F, C08B]
8603454 Cyclodextrin-based polymers for therapeutics deliveryFeb 15, 13Dec 10, 13[A61K, C08G, C08F, C08B]
8580242 Cyclodextrin-based polymers for therapeutics deliveryJan 11, 13Nov 12, 13[A61K, C08G, C08F, C08B]
8580243 Cyclodextrin-based polymers for therapeutics deliveryFeb 15, 13Nov 12, 13[A61K, C08G, C08F, C08B]
					Expired/Abandoned/Withdrawn Patents
						
							Patent #
							Title
							Status
							Filing Date
							Issue/Pub Date
							Intl Class
						
					
					
					2016/0058,874 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERYAbandonedMar 25, 15Mar 03, 16[A61K]
2015/0209,440 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USEAbandonedApr 09, 15Jul 30, 15[A61K, C12N]
2015/0165,055 CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETOAbandonedJul 21, 14Jun 18, 15[A61K, C08G, C08F, G06Q]
2015/0141,638 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERYAbandonedJun 18, 14May 21, 15[A61K, C08B]
2015/0005,230 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERYAbandonedJan 30, 14Jan 01, 15[A61K]
2014/0357,557 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERYAbandonedMay 30, 14Dec 04, 14[A61K]
2014/0328,918 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONSAbandonedDec 11, 13Nov 06, 14[A61K]
2014/0328,919 POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USEAbandonedDec 17, 13Nov 06, 14[A61K]
2014/0296,322 CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USEAbandonedApr 18, 14Oct 02, 14[A61K, C12N]
2014/0286,873 POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USEAbandonedOct 08, 13Sep 25, 14[A61K]
2014/0288,024 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERYAbandonedOct 25, 13Sep 25, 14[A61K]
2014/0274,947 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERYAbandonedSep 19, 13Sep 18, 14[A61K]
2014/0255,374 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASEAbandonedNov 06, 13Sep 11, 14[A61K]
2014/0213,504 Cyclodextrin-Based Polymers for Therapeutic DeliveryAbandonedNov 25, 13Jul 31, 14[A61K]
2014/0199,370 CYCLODEXTRIN-BASED MATERIALS COMPOSITIONS AND USES RELATED THERETOAbandonedAug 15, 13Jul 17, 14[A61K]
2014/0193,510 Polymer-Agent Conjugates, Particles, Compositions, and Related Methods of UseAbandonedFeb 13, 14Jul 10, 14[A61K]
					Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More | 
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
